Learn More
Novus Biologicals™ Fibroblast Activation Protein alpha/FAP Antibody (sibrotuzumab) - Humanized, Novus Biologicals™

Human Monoclonal Antibody
Supplier: Novus Biologicals™ NBP328536100UG
Description
Fibroblast Activation Protein alpha/FAP Monoclonal antibody specifically detects Fibroblast Activation Protein alpha/FAP in Human samples. It is validated for Flow Cytometry,ELISA,Functional AssaySpecifications
Fibroblast Activation Protein alpha/FAP | |
Monoclonal | |
Unconjugated | |
Q12884 | |
Human | |
Protein A purified | |
RUO | |
Primary | |
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
Store at -20°C in powder form. Store at -80°C once reconstituted. | |
IgG1 |
Flow Cytometry, ELISA, Functional Assay | |
sibrotuzumab | |
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
170 kDa melanoma membrane-bound gelatinase, DKFZp686G13158, DPPIV, EC 3.4.21.-, FAPA, Fibroblast activation protein alpha, fibroblast activation protein, alpha, Integral membrane serine protease, seprase, vibronectin | |
FAP | |
100 μg | |
Cancer, Protein Phosphatase | |
2191 | |
Human | |
Purified |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.